Global BiSpecific MAbS Supply, Demand and Key Producers, 2023-2029
The global BiSpecific MAbS market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global BiSpecific MAbS demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for BiSpecific MAbS, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of BiSpecific MAbS that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global BiSpecific MAbS total market, 2018-2029, (USD Million)
Global BiSpecific MAbS total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: BiSpecific MAbS total market, key domestic companies and share, (USD Million)
Global BiSpecific MAbS revenue by player and market share 2018-2023, (USD Million)
Global BiSpecific MAbS total market by Type, CAGR, 2018-2029, (USD Million)
Global BiSpecific MAbS total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global BiSpecific MAbS market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Bristol Myers Squibb and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World BiSpecific MAbS market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global BiSpecific MAbS Market, By Region:
1. How big is the global BiSpecific MAbS market?
2. What is the demand of the global BiSpecific MAbS market?
3. What is the year over year growth of the global BiSpecific MAbS market?
4. What is the total value of the global BiSpecific MAbS market?
5. Who are the major players in the global BiSpecific MAbS market?
6. What are the growth factors driving the market demand?
This report studies the global BiSpecific MAbS demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for BiSpecific MAbS, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of BiSpecific MAbS that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global BiSpecific MAbS total market, 2018-2029, (USD Million)
Global BiSpecific MAbS total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: BiSpecific MAbS total market, key domestic companies and share, (USD Million)
Global BiSpecific MAbS revenue by player and market share 2018-2023, (USD Million)
Global BiSpecific MAbS total market by Type, CAGR, 2018-2029, (USD Million)
Global BiSpecific MAbS total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global BiSpecific MAbS market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Bristol Myers Squibb and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World BiSpecific MAbS market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global BiSpecific MAbS Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Catumaxomab (Removab™)
- Blinatumomab
- Emicizumab
- Amivantamab
- Others
- Hospital
- Research Institute
- Others
- Johnson & Johnson
- Novartis AG
- Hoffmann-La Roche Ltd.
- Novo Nordisk A/S
- Bayer AG
- Thermo Fisher Scientific
- Bristol Myers Squibb
- Abbott
1. How big is the global BiSpecific MAbS market?
2. What is the demand of the global BiSpecific MAbS market?
3. What is the year over year growth of the global BiSpecific MAbS market?
4. What is the total value of the global BiSpecific MAbS market?
5. Who are the major players in the global BiSpecific MAbS market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 BiSpecific MAbS Introduction
1.2 World BiSpecific MAbS Market Size & Forecast (2018 & 2022 & 2029)
1.3 World BiSpecific MAbS Total Market by Region (by Headquarter Location)
1.3.1 World BiSpecific MAbS Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States BiSpecific MAbS Market Size (2018-2029)
1.3.3 China BiSpecific MAbS Market Size (2018-2029)
1.3.4 Europe BiSpecific MAbS Market Size (2018-2029)
1.3.5 Japan BiSpecific MAbS Market Size (2018-2029)
1.3.6 South Korea BiSpecific MAbS Market Size (2018-2029)
1.3.7 ASEAN BiSpecific MAbS Market Size (2018-2029)
1.3.8 India BiSpecific MAbS Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 BiSpecific MAbS Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 BiSpecific MAbS Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World BiSpecific MAbS Consumption Value (2018-2029)
2.2 World BiSpecific MAbS Consumption Value by Region
2.2.1 World BiSpecific MAbS Consumption Value by Region (2018-2023)
2.2.2 World BiSpecific MAbS Consumption Value Forecast by Region (2024-2029)
2.3 United States BiSpecific MAbS Consumption Value (2018-2029)
2.4 China BiSpecific MAbS Consumption Value (2018-2029)
2.5 Europe BiSpecific MAbS Consumption Value (2018-2029)
2.6 Japan BiSpecific MAbS Consumption Value (2018-2029)
2.7 South Korea BiSpecific MAbS Consumption Value (2018-2029)
2.8 ASEAN BiSpecific MAbS Consumption Value (2018-2029)
2.9 India BiSpecific MAbS Consumption Value (2018-2029)
3 WORLD BISPECIFIC MABS COMPANIES COMPETITIVE ANALYSIS
3.1 World BiSpecific MAbS Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global BiSpecific MAbS Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for BiSpecific MAbS in 2022
3.2.3 Global Concentration Ratios (CR8) for BiSpecific MAbS in 2022
3.3 BiSpecific MAbS Company Evaluation Quadrant
3.4 BiSpecific MAbS Market: Overall Company Footprint Analysis
3.4.1 BiSpecific MAbS Market: Region Footprint
3.4.2 BiSpecific MAbS Market: Company Product Type Footprint
3.4.3 BiSpecific MAbS Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: BiSpecific MAbS Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: BiSpecific MAbS Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: BiSpecific MAbS Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: BiSpecific MAbS Consumption Value Comparison
4.2.1 United States VS China: BiSpecific MAbS Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: BiSpecific MAbS Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based BiSpecific MAbS Companies and Market Share, 2018-2023
4.3.1 United States Based BiSpecific MAbS Companies, Headquarters (States, Country)
4.3.2 United States Based Companies BiSpecific MAbS Revenue, (2018-2023)
4.4 China Based Companies BiSpecific MAbS Revenue and Market Share, 2018-2023
4.4.1 China Based BiSpecific MAbS Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies BiSpecific MAbS Revenue, (2018-2023)
4.5 Rest of World Based BiSpecific MAbS Companies and Market Share, 2018-2023
4.5.1 Rest of World Based BiSpecific MAbS Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies BiSpecific MAbS Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World BiSpecific MAbS Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Catumaxomab (Removab™)
5.2.2 Blinatumomab
5.2.3 Emicizumab
5.2.4 Amivantamab
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World BiSpecific MAbS Market Size by Type (2018-2023)
5.3.2 World BiSpecific MAbS Market Size by Type (2024-2029)
5.3.3 World BiSpecific MAbS Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World BiSpecific MAbS Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World BiSpecific MAbS Market Size by Application (2018-2023)
6.3.2 World BiSpecific MAbS Market Size by Application (2024-2029)
6.3.3 World BiSpecific MAbS Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson BiSpecific MAbS Product and Services
7.1.4 Johnson & Johnson BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 Novartis AG
7.2.1 Novartis AG Details
7.2.2 Novartis AG Major Business
7.2.3 Novartis AG BiSpecific MAbS Product and Services
7.2.4 Novartis AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis AG Recent Developments/Updates
7.2.6 Novartis AG Competitive Strengths & Weaknesses
7.3 Hoffmann-La Roche Ltd.
7.3.1 Hoffmann-La Roche Ltd. Details
7.3.2 Hoffmann-La Roche Ltd. Major Business
7.3.3 Hoffmann-La Roche Ltd. BiSpecific MAbS Product and Services
7.3.4 Hoffmann-La Roche Ltd. BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
7.3.6 Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.4 Novo Nordisk A/S
7.4.1 Novo Nordisk A/S Details
7.4.2 Novo Nordisk A/S Major Business
7.4.3 Novo Nordisk A/S BiSpecific MAbS Product and Services
7.4.4 Novo Nordisk A/S BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novo Nordisk A/S Recent Developments/Updates
7.4.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.5 Bayer AG
7.5.1 Bayer AG Details
7.5.2 Bayer AG Major Business
7.5.3 Bayer AG BiSpecific MAbS Product and Services
7.5.4 Bayer AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bayer AG Recent Developments/Updates
7.5.6 Bayer AG Competitive Strengths & Weaknesses
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Details
7.6.2 Thermo Fisher Scientific Major Business
7.6.3 Thermo Fisher Scientific BiSpecific MAbS Product and Services
7.6.4 Thermo Fisher Scientific BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Details
7.7.2 Bristol Myers Squibb Major Business
7.7.3 Bristol Myers Squibb BiSpecific MAbS Product and Services
7.7.4 Bristol Myers Squibb BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bristol Myers Squibb Recent Developments/Updates
7.7.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.8 Abbott
7.8.1 Abbott Details
7.8.2 Abbott Major Business
7.8.3 Abbott BiSpecific MAbS Product and Services
7.8.4 Abbott BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Abbott Recent Developments/Updates
7.8.6 Abbott Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 BiSpecific MAbS Industry Chain
8.2 BiSpecific MAbS Upstream Analysis
8.3 BiSpecific MAbS Midstream Analysis
8.4 BiSpecific MAbS Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 BiSpecific MAbS Introduction
1.2 World BiSpecific MAbS Market Size & Forecast (2018 & 2022 & 2029)
1.3 World BiSpecific MAbS Total Market by Region (by Headquarter Location)
1.3.1 World BiSpecific MAbS Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States BiSpecific MAbS Market Size (2018-2029)
1.3.3 China BiSpecific MAbS Market Size (2018-2029)
1.3.4 Europe BiSpecific MAbS Market Size (2018-2029)
1.3.5 Japan BiSpecific MAbS Market Size (2018-2029)
1.3.6 South Korea BiSpecific MAbS Market Size (2018-2029)
1.3.7 ASEAN BiSpecific MAbS Market Size (2018-2029)
1.3.8 India BiSpecific MAbS Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 BiSpecific MAbS Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 BiSpecific MAbS Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World BiSpecific MAbS Consumption Value (2018-2029)
2.2 World BiSpecific MAbS Consumption Value by Region
2.2.1 World BiSpecific MAbS Consumption Value by Region (2018-2023)
2.2.2 World BiSpecific MAbS Consumption Value Forecast by Region (2024-2029)
2.3 United States BiSpecific MAbS Consumption Value (2018-2029)
2.4 China BiSpecific MAbS Consumption Value (2018-2029)
2.5 Europe BiSpecific MAbS Consumption Value (2018-2029)
2.6 Japan BiSpecific MAbS Consumption Value (2018-2029)
2.7 South Korea BiSpecific MAbS Consumption Value (2018-2029)
2.8 ASEAN BiSpecific MAbS Consumption Value (2018-2029)
2.9 India BiSpecific MAbS Consumption Value (2018-2029)
3 WORLD BISPECIFIC MABS COMPANIES COMPETITIVE ANALYSIS
3.1 World BiSpecific MAbS Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global BiSpecific MAbS Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for BiSpecific MAbS in 2022
3.2.3 Global Concentration Ratios (CR8) for BiSpecific MAbS in 2022
3.3 BiSpecific MAbS Company Evaluation Quadrant
3.4 BiSpecific MAbS Market: Overall Company Footprint Analysis
3.4.1 BiSpecific MAbS Market: Region Footprint
3.4.2 BiSpecific MAbS Market: Company Product Type Footprint
3.4.3 BiSpecific MAbS Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: BiSpecific MAbS Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: BiSpecific MAbS Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: BiSpecific MAbS Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: BiSpecific MAbS Consumption Value Comparison
4.2.1 United States VS China: BiSpecific MAbS Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: BiSpecific MAbS Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based BiSpecific MAbS Companies and Market Share, 2018-2023
4.3.1 United States Based BiSpecific MAbS Companies, Headquarters (States, Country)
4.3.2 United States Based Companies BiSpecific MAbS Revenue, (2018-2023)
4.4 China Based Companies BiSpecific MAbS Revenue and Market Share, 2018-2023
4.4.1 China Based BiSpecific MAbS Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies BiSpecific MAbS Revenue, (2018-2023)
4.5 Rest of World Based BiSpecific MAbS Companies and Market Share, 2018-2023
4.5.1 Rest of World Based BiSpecific MAbS Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies BiSpecific MAbS Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World BiSpecific MAbS Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Catumaxomab (Removab™)
5.2.2 Blinatumomab
5.2.3 Emicizumab
5.2.4 Amivantamab
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World BiSpecific MAbS Market Size by Type (2018-2023)
5.3.2 World BiSpecific MAbS Market Size by Type (2024-2029)
5.3.3 World BiSpecific MAbS Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World BiSpecific MAbS Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Institute
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World BiSpecific MAbS Market Size by Application (2018-2023)
6.3.2 World BiSpecific MAbS Market Size by Application (2024-2029)
6.3.3 World BiSpecific MAbS Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson BiSpecific MAbS Product and Services
7.1.4 Johnson & Johnson BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 Novartis AG
7.2.1 Novartis AG Details
7.2.2 Novartis AG Major Business
7.2.3 Novartis AG BiSpecific MAbS Product and Services
7.2.4 Novartis AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis AG Recent Developments/Updates
7.2.6 Novartis AG Competitive Strengths & Weaknesses
7.3 Hoffmann-La Roche Ltd.
7.3.1 Hoffmann-La Roche Ltd. Details
7.3.2 Hoffmann-La Roche Ltd. Major Business
7.3.3 Hoffmann-La Roche Ltd. BiSpecific MAbS Product and Services
7.3.4 Hoffmann-La Roche Ltd. BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
7.3.6 Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.4 Novo Nordisk A/S
7.4.1 Novo Nordisk A/S Details
7.4.2 Novo Nordisk A/S Major Business
7.4.3 Novo Nordisk A/S BiSpecific MAbS Product and Services
7.4.4 Novo Nordisk A/S BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novo Nordisk A/S Recent Developments/Updates
7.4.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.5 Bayer AG
7.5.1 Bayer AG Details
7.5.2 Bayer AG Major Business
7.5.3 Bayer AG BiSpecific MAbS Product and Services
7.5.4 Bayer AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bayer AG Recent Developments/Updates
7.5.6 Bayer AG Competitive Strengths & Weaknesses
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Details
7.6.2 Thermo Fisher Scientific Major Business
7.6.3 Thermo Fisher Scientific BiSpecific MAbS Product and Services
7.6.4 Thermo Fisher Scientific BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Details
7.7.2 Bristol Myers Squibb Major Business
7.7.3 Bristol Myers Squibb BiSpecific MAbS Product and Services
7.7.4 Bristol Myers Squibb BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bristol Myers Squibb Recent Developments/Updates
7.7.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.8 Abbott
7.8.1 Abbott Details
7.8.2 Abbott Major Business
7.8.3 Abbott BiSpecific MAbS Product and Services
7.8.4 Abbott BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Abbott Recent Developments/Updates
7.8.6 Abbott Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 BiSpecific MAbS Industry Chain
8.2 BiSpecific MAbS Upstream Analysis
8.3 BiSpecific MAbS Midstream Analysis
8.4 BiSpecific MAbS Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World BiSpecific MAbS Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World BiSpecific MAbS Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World BiSpecific MAbS Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World BiSpecific MAbS Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World BiSpecific MAbS Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World BiSpecific MAbS Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World BiSpecific MAbS Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World BiSpecific MAbS Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World BiSpecific MAbS Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key BiSpecific MAbS Players in 2022
Table 12. World BiSpecific MAbS Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global BiSpecific MAbS Company Evaluation Quadrant
Table 14. Head Office of Key BiSpecific MAbS Player
Table 15. BiSpecific MAbS Market: Company Product Type Footprint
Table 16. BiSpecific MAbS Market: Company Product Application Footprint
Table 17. BiSpecific MAbS Mergers & Acquisitions Activity
Table 18. United States VS China BiSpecific MAbS Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China BiSpecific MAbS Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based BiSpecific MAbS Companies, Headquarters (States, Country)
Table 21. United States Based Companies BiSpecific MAbS Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies BiSpecific MAbS Revenue Market Share (2018-2023)
Table 23. China Based BiSpecific MAbS Companies, Headquarters (Province, Country)
Table 24. China Based Companies BiSpecific MAbS Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies BiSpecific MAbS Revenue Market Share (2018-2023)
Table 26. Rest of World Based BiSpecific MAbS Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies BiSpecific MAbS Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies BiSpecific MAbS Revenue Market Share (2018-2023)
Table 29. World BiSpecific MAbS Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World BiSpecific MAbS Market Size by Type (2018-2023) & (USD Million)
Table 31. World BiSpecific MAbS Market Size by Type (2024-2029) & (USD Million)
Table 32. World BiSpecific MAbS Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World BiSpecific MAbS Market Size by Application (2018-2023) & (USD Million)
Table 34. World BiSpecific MAbS Market Size by Application (2024-2029) & (USD Million)
Table 35. Johnson & Johnson Basic Information, Area Served and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson BiSpecific MAbS Product and Services
Table 38. Johnson & Johnson BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Johnson & Johnson Recent Developments/Updates
Table 40. Johnson & Johnson Competitive Strengths & Weaknesses
Table 41. Novartis AG Basic Information, Area Served and Competitors
Table 42. Novartis AG Major Business
Table 43. Novartis AG BiSpecific MAbS Product and Services
Table 44. Novartis AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis AG Recent Developments/Updates
Table 46. Novartis AG Competitive Strengths & Weaknesses
Table 47. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 48. Hoffmann-La Roche Ltd. Major Business
Table 49. Hoffmann-La Roche Ltd. BiSpecific MAbS Product and Services
Table 50. Hoffmann-La Roche Ltd. BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 52. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 53. Novo Nordisk A/S Basic Information, Area Served and Competitors
Table 54. Novo Nordisk A/S Major Business
Table 55. Novo Nordisk A/S BiSpecific MAbS Product and Services
Table 56. Novo Nordisk A/S BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novo Nordisk A/S Recent Developments/Updates
Table 58. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 59. Bayer AG Basic Information, Area Served and Competitors
Table 60. Bayer AG Major Business
Table 61. Bayer AG BiSpecific MAbS Product and Services
Table 62. Bayer AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bayer AG Recent Developments/Updates
Table 64. Bayer AG Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific BiSpecific MAbS Product and Services
Table 68. Thermo Fisher Scientific BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 72. Bristol Myers Squibb Major Business
Table 73. Bristol Myers Squibb BiSpecific MAbS Product and Services
Table 74. Bristol Myers Squibb BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bristol Myers Squibb Recent Developments/Updates
Table 76. Abbott Basic Information, Area Served and Competitors
Table 77. Abbott Major Business
Table 78. Abbott BiSpecific MAbS Product and Services
Table 79. Abbott BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of BiSpecific MAbS Upstream (Raw Materials)
Table 81. BiSpecific MAbS Typical Customers
Table 1. World BiSpecific MAbS Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World BiSpecific MAbS Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World BiSpecific MAbS Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World BiSpecific MAbS Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World BiSpecific MAbS Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World BiSpecific MAbS Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World BiSpecific MAbS Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World BiSpecific MAbS Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World BiSpecific MAbS Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key BiSpecific MAbS Players in 2022
Table 12. World BiSpecific MAbS Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global BiSpecific MAbS Company Evaluation Quadrant
Table 14. Head Office of Key BiSpecific MAbS Player
Table 15. BiSpecific MAbS Market: Company Product Type Footprint
Table 16. BiSpecific MAbS Market: Company Product Application Footprint
Table 17. BiSpecific MAbS Mergers & Acquisitions Activity
Table 18. United States VS China BiSpecific MAbS Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China BiSpecific MAbS Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based BiSpecific MAbS Companies, Headquarters (States, Country)
Table 21. United States Based Companies BiSpecific MAbS Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies BiSpecific MAbS Revenue Market Share (2018-2023)
Table 23. China Based BiSpecific MAbS Companies, Headquarters (Province, Country)
Table 24. China Based Companies BiSpecific MAbS Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies BiSpecific MAbS Revenue Market Share (2018-2023)
Table 26. Rest of World Based BiSpecific MAbS Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies BiSpecific MAbS Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies BiSpecific MAbS Revenue Market Share (2018-2023)
Table 29. World BiSpecific MAbS Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World BiSpecific MAbS Market Size by Type (2018-2023) & (USD Million)
Table 31. World BiSpecific MAbS Market Size by Type (2024-2029) & (USD Million)
Table 32. World BiSpecific MAbS Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World BiSpecific MAbS Market Size by Application (2018-2023) & (USD Million)
Table 34. World BiSpecific MAbS Market Size by Application (2024-2029) & (USD Million)
Table 35. Johnson & Johnson Basic Information, Area Served and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson BiSpecific MAbS Product and Services
Table 38. Johnson & Johnson BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Johnson & Johnson Recent Developments/Updates
Table 40. Johnson & Johnson Competitive Strengths & Weaknesses
Table 41. Novartis AG Basic Information, Area Served and Competitors
Table 42. Novartis AG Major Business
Table 43. Novartis AG BiSpecific MAbS Product and Services
Table 44. Novartis AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis AG Recent Developments/Updates
Table 46. Novartis AG Competitive Strengths & Weaknesses
Table 47. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 48. Hoffmann-La Roche Ltd. Major Business
Table 49. Hoffmann-La Roche Ltd. BiSpecific MAbS Product and Services
Table 50. Hoffmann-La Roche Ltd. BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 52. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 53. Novo Nordisk A/S Basic Information, Area Served and Competitors
Table 54. Novo Nordisk A/S Major Business
Table 55. Novo Nordisk A/S BiSpecific MAbS Product and Services
Table 56. Novo Nordisk A/S BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novo Nordisk A/S Recent Developments/Updates
Table 58. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 59. Bayer AG Basic Information, Area Served and Competitors
Table 60. Bayer AG Major Business
Table 61. Bayer AG BiSpecific MAbS Product and Services
Table 62. Bayer AG BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bayer AG Recent Developments/Updates
Table 64. Bayer AG Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific BiSpecific MAbS Product and Services
Table 68. Thermo Fisher Scientific BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 72. Bristol Myers Squibb Major Business
Table 73. Bristol Myers Squibb BiSpecific MAbS Product and Services
Table 74. Bristol Myers Squibb BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bristol Myers Squibb Recent Developments/Updates
Table 76. Abbott Basic Information, Area Served and Competitors
Table 77. Abbott Major Business
Table 78. Abbott BiSpecific MAbS Product and Services
Table 79. Abbott BiSpecific MAbS Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of BiSpecific MAbS Upstream (Raw Materials)
Table 81. BiSpecific MAbS Typical Customers
LIST OF FIGURES
Figure 1. BiSpecific MAbS Picture
Figure 2. World BiSpecific MAbS Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World BiSpecific MAbS Total Market Size (2018-2029) & (USD Million)
Figure 4. World BiSpecific MAbS Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World BiSpecific MAbS Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 13. BiSpecific MAbS Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 16. World BiSpecific MAbS Consumption Value Market Share by Region (2018-2029)
Figure 17. United States BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 18. China BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 23. India BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of BiSpecific MAbS by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for BiSpecific MAbS Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for BiSpecific MAbS Markets in 2022
Figure 27. United States VS China: BiSpecific MAbS Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: BiSpecific MAbS Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World BiSpecific MAbS Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World BiSpecific MAbS Market Size Market Share by Type in 2022
Figure 31. Catumaxomab (Removab™)
Figure 32. Blinatumomab
Figure 33. Emicizumab
Figure 34. Amivantamab
Figure 35. Others
Figure 36. World BiSpecific MAbS Market Size Market Share by Type (2018-2029)
Figure 37. World BiSpecific MAbS Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World BiSpecific MAbS Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Research Institute
Figure 41. Others
Figure 42. BiSpecific MAbS Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. BiSpecific MAbS Picture
Figure 2. World BiSpecific MAbS Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World BiSpecific MAbS Total Market Size (2018-2029) & (USD Million)
Figure 4. World BiSpecific MAbS Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World BiSpecific MAbS Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company BiSpecific MAbS Revenue (2018-2029) & (USD Million)
Figure 13. BiSpecific MAbS Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 16. World BiSpecific MAbS Consumption Value Market Share by Region (2018-2029)
Figure 17. United States BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 18. China BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 23. India BiSpecific MAbS Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of BiSpecific MAbS by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for BiSpecific MAbS Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for BiSpecific MAbS Markets in 2022
Figure 27. United States VS China: BiSpecific MAbS Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: BiSpecific MAbS Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World BiSpecific MAbS Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World BiSpecific MAbS Market Size Market Share by Type in 2022
Figure 31. Catumaxomab (Removab™)
Figure 32. Blinatumomab
Figure 33. Emicizumab
Figure 34. Amivantamab
Figure 35. Others
Figure 36. World BiSpecific MAbS Market Size Market Share by Type (2018-2029)
Figure 37. World BiSpecific MAbS Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World BiSpecific MAbS Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Research Institute
Figure 41. Others
Figure 42. BiSpecific MAbS Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
